Related Experiment Video
Updated: May 27, 2026

Performing and Processing FNA of Anterior Fat Pad for Amyloid
Published on: October 30, 2010
Is there a real adrenal axis dysfunction in patients with amyloidosis associated with familial Mediterranean fever?
Guven Yılmaz1, Seval Masatlioglu, Demet Ozgil Yetkin
1Haydarpaşa Numune Training and Research Hospital, Istanbul, Turkey.
Abstract:
Systemic amyloidosis with AA-type amyloid deposition is the major complication of FMF, leading to end stage renal disease. There is no clear data on the prevalence of adrenal involvement in patients with FMF amyloidosis. The aim of this study is to determine the adrenal axis function in patients FMF with amyloidosis. Twenty patients with FMF with amyloidosis (F/M: 10/10, mean age; 38 ± 11 SD years), twenty without amyloidosis (F/M: 14/6, mean age 32 ± 10 years), and healthy controls (F/M: 12/8, mean age: 30 ± 7.6 SD years) were recruited. A dose of 250 mg tetracosactide (Synacthen) was then administered intravenously and further blood samples collected 30 and 60 min later. Blood samples were separated and collected at 4°C, and serum cortisol levels were measured. A normal cortisol response to Synacthen was defined as a post-stimulation peak cortisol value of >18 mg/d either at 30 or 60 min. sample. The mean disease duration was 8.8 ± 6 SD years, (range, 2-21) in FMF patients without amyloidosis compared to 16 ± 9.5 years (range, 0-30) in FMF with amyloidosis (P = 0.001). The cortisol concentrations increased significantly at 30 and 60 min compared to baseline after injection of synacthen in all groups. There were no statistically significant differences found among three groups, for basal, 30 and 60 min for cortisol levels (P = 0.154). FMF patients with amyloidosis do not exhibit overt adrenal insufficiency even though their basal cortisol levels were mildly lower.
Insights
Patients with Familial Mediterranean Fever (FMF) and amyloidosis show normal adrenal function despite mildly lower baseline cortisol. This study assessed adrenal axis function in FMF patients with and without amyloidosis.
Area of Science:
- Endocrinology
- Rheumatology
- Nephrology
Background:
- Systemic amyloidosis, particularly AA-type, is a significant complication of Familial Mediterranean Fever (FMF).
- AA-type amyloidosis in FMF can lead to end-stage renal disease, highlighting the systemic impact of the condition.
- The prevalence and impact of adrenal involvement in FMF patients with amyloidosis remain unclear.
Purpose of the Study:
- To investigate and determine the adrenal axis function in patients diagnosed with Familial Mediterranean Fever (FMF) and concurrent amyloidosis.
- To compare adrenal function between FMF patients with amyloidosis, FMF patients without amyloidosis, and healthy controls.
- To assess for overt adrenal insufficiency in FMF patients experiencing amyloid deposition.
Main Methods:
- Recruitment of three groups: 20 FMF patients with amyloidosis, 20 FMF patients without amyloidosis, and 20 healthy controls.
- Intravenous administration of 250 mg tetracosactide (Synacthen) to stimulate the adrenal axis.
- Measurement of serum cortisol levels at baseline, 30 minutes, and 60 minutes post-Synacthen injection.
Main Results:
- A normal cortisol response to Synacthen was defined as a peak cortisol level >18 mg/dL at 30 or 60 minutes post-injection.
- Cortisol levels significantly increased from baseline in all groups after Synacthen administration.
- No statistically significant differences in basal, 30-min, or 60-min cortisol levels were observed among the three groups (P = 0.154).
Conclusions:
- FMF patients with amyloidosis do not exhibit overt adrenal insufficiency.
- While basal cortisol levels may be mildly lower in FMF patients with amyloidosis, their adrenal axis remains responsive.
- These findings suggest that amyloid deposition in FMF does not typically lead to clinically significant adrenal dysfunction.
Related Concept Videos
Adrenal Gland Disorders
Adrenal insufficiency, characterized by insufficient cortisol and aldosterone production, leads to conditions like Addison's disease. This disorder, affecting the adrenal cortex, exhibits symptoms such as skin bronzing, dehydration, low blood pressure, fatigue, and weight loss. Congenital adrenal hyperplasia, a genetic ailment causing...
Cushing Syndrome II: Pathophysiology
Cushing Syndrome I: Introduction
Amyloid Fibrils
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining, normally used to...
Amyloid Fibrils
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining, normally used to...
Hormones of the Adrenal Glands
The adrenal cortex, a powerhouse of hormone synthesis, generates over two dozen corticosteroid hormones. The zona glomerulosa produces mineralocorticoids, exemplified by aldosterone, influencing the electrolyte composition of body fluids. The synthesis of glucocorticoids such as cortisol and corticosterone...

